Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Connie Matsui currently holds 50,000 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Connie Matsui has been a net seller of HALO stock. They have purchased $90.0K and sold $16.4M worth of shares.
Connie Matsui's most recent insider trade was on Oct 15, 2025, when they purchased 50,000 shares at $0.80 per share.
Connie Matsui serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 101 insider transactions totaling $16.5M over their tenure at the company.
Connie Matsui holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Connie Matsui has shown a selling trading pattern, with $90.0K in total purchases and $16.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Connie Matsui was on Sep 11, 2020, when they sold $865.9K worth of HALO shares. This transaction involved 32,000 shares at $27.06 per share.
Connie Matsui currently owns 50,000 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Connie Matsui's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Connie Matsui has 101 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Connie Matsui and 40,000+ other insiders.